HBV-IN-36 (also known as compound 42) is a hepatitis B virus (HBV) inhibitor with an IC50 of 2 µM, exhibiting anti-HBV activity characterized by an EC50 of 0.58 µM [1].
Molecular Weight:
412.84
Formula:
C21H18ClFN4O2
Target:
HBV
* VAT and and shipping costs not included. Errors and price changes excepted